miR-9 knockdown inhibits hypoxia-induced cardiomyocyte apoptosis by targeting Yap1

Jiayong Zheng1, Bangtian Peng1, Yanwei Zhang1

  • 1Department of Children's Heart Center, Henan Provincial People's Hospital, Fuwai Central China Cardiovascular Hospital, No. 1 Fuwai Avenue, Zhengzhou 450000, China.

Life Sciences
|January 15, 2019
PubMed

Insights

MicroRNA-9 (miR-9) knockdown protects cardiomyocytes from hypoxia-induced apoptosis by targeting Yes-associated protein 1 (Yap1). This study reveals a novel mechanism for cardiomyocyte adaptation to chronic hypoxia.

Area of Science:

  • Cardiovascular Biology
  • Molecular Biology
  • Cellular Physiology

Background:

  • Aberrantly expressed microRNAs (miRNAs) play a role in congenital heart disease (CHD).
  • miR-9 is upregulated in cardiac tissues of CHD patients.
  • The function and mechanism of miR-9 in hypoxia-induced cardiomyocytes remain unclear.

Purpose of the Study:

  • To investigate the role of miR-9 in hypoxia-induced cardiomyocyte apoptosis.
  • To elucidate the underlying molecular mechanism involving Yes-associated protein 1 (Yap1).

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) and Western blot to assess miR-9 and Yap1 expression.
  • Cell Counting Kit-8 (CCK-8), flow cytometry, and caspase-3/7 activity assays to evaluate cell viability, apoptosis, and activity.
  • Luciferase reporter assays to confirm the interaction between miR-9 and Yap1.

Main Results:

  • Hypoxia upregulated miR-9 and downregulated Yap1 in H9c2 cells.
  • miR-9 knockdown enhanced cell proliferation and inhibited apoptosis under hypoxia.
  • Yap1 was identified as a direct target of miR-9, and its knockdown mimicked miR-9's effects on cell proliferation and apoptosis.

Conclusions:

  • miR-9 knockdown mitigates hypoxia-induced cardiomyocyte apoptosis by targeting Yap1.
  • This study offers new insights into the adaptive mechanisms of cardiomyocytes under chronic hypoxic conditions.
Abstract

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
14.5K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.1K
Hypoxia01:23

Hypoxia

Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
2.1K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K